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Abstract
Background: Aging has been associated with widespread changes at the gene expression level in
multiple mammalian tissues. We have used high density oligonucleotide arrays and novel statistical
methods to identify specific transcriptional classes that may uncover biological processes that play
a central role in mammalian aging.
Results: We identified 712 transcripts that are differentially expressed in young (5 month old) and
old (25-month old) mouse skeletal muscle. Caloric restriction (CR) completely or partially
reversed 87% of the changes in expression. Examination of individual genes revealed a
transcriptional profile indicative of increased p53 activity in the older muscle. To determine
whether the increase in p53 activity is associated with transcriptional activation of apoptotic
targets, we performed RT-PCR on four well known mediators of p53-induced apoptosis: puma,
noxa, tnfrsf10b and bok. Expression levels for these proapoptotic genes increased significantly with
age (P < 0.05), while CR significantly lowered expression levels for these genes as compared to
control fed old mice (P < 0.05). Age-related induction of p53-related genes was observed in
multiple tissues, but was not observed in young SOD2+/- and GPX4+/- mice, suggesting that
oxidative stress does not induce the expression of these genes. Western blot analysis confirmed
that protein levels for both p21 and GADD45a, two established transcriptional targets of p53, were
higher in the older muscle tissue.
Conclusion: These observations support a role for p53-mediated transcriptional program in
mammalian aging and suggest that mechanisms other than reactive oxygen species are involved in
the age-related transcriptional activation of p53 targets.
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Background
Aging in skeletal muscle is characterized by loss of motor
neurons, variations in size and type of muscle fibers, infil-
tration of fat and connective tissue, and a overall decrease
in muscle mass (sarcopenia) [1]. Sarcopenia, the leading
cause of frailty and disability in the elderly, has also been
linked to other age-associated pathology, such as oste-
oporosis and impaired thermoregulation [2-5]. Several
biological processes, such as an increase in inflammatory
cytokines and a decrease in sex and growth hormones
with age [6-8], have been suggested as contributing factors
to the aging of skeletal muscle. At the cellular level, older
muscle is associated with decreased protein synthesis [9],
an increase in DNA, protein and lipid oxidation [10,11],
and the accumulation of mitochondrial abnormalities
[12].
Several studies have employed microarray technology to
uncover changes in gene expression that accompany aging
in skeletal muscle of mice [13], rats [14], monkeys [15]
and humans [16,17]. When taken as a whole, results
obtained from these studies suggest that the expression of
genes indicative of cellular damage, such as those
involved in the stress or inflammatory response, increase
with age, while expression of metabolic and biosynthetic
genes decrease with aging. We had previously investigated
age-related changes in gene expression of mouse gastroc-
nemius tissue using high density oligonucleotide arrays
[13], but our study was limited by low sample number (3
mice per age group), an arbitrary fold change criteria (>
1.5 fold difference) with no statistical analysis to deter-
mine differentially expressed genes, and a limited survey
of genes expressed in the mouse genome (6347 tran-
scripts). We therefore decided to expand our initial inves-
tigation using a larger sample size (5 mice per age group),
a stringent statistical criteria to determine differentially
expressed genes [posterior probability (PP) > 0.90], and a
greater representation of the mouse genome (22,690 tran-
scripts). Our current microarray study of young and old
C57BL/6NHsd mice supports previous findings on spe-
cific transcript classes differentially expressed with aging
and also suggests that increased p53 activity in skeletal
muscle of older animals may contribute to aging pheno-
types. Caloric restriction, which extends the life span of
this strain of mice by approximately 40%, prevents the
majority of the changes in gene expression observed in the
older mice under the control diet.
Results
General
We used an empirical Bayes (EB) hierarchical modeling
approach called EBarrays to identify 712 genes differen-
tially expressed [posterior probability (PP) > .90] in old
mouse gastrocnemius tissue [see additional file 1]. There
are a number of advantages to our statistical approach.
The main ones are the ability to combine information
across genes and the dual nature of posterior probabili-
ties. The posterior probabilities quantify evidence in favor
of differential expression; however, unlike classic p-val-
ues, they can also be used to measure evidence in favor of
equivalent expression. Measurements taken from gastroc-
nemius tissue from a group of old mice on caloric restric-
tion (CR, n = 5), a regimen previously shown to increase
lifespan and retard aging parameters in mice, was used as
a negative control to aging. There were 311 genes with
higher expression in the young animals and 401 genes
with greater expression in the old. As expected, CR com-
pletely or partially reversed 87% of the genes with age-
associated changes in expression (partial CR reversal was
determined as > 25% CR effect). In agreement with previ-
ous microarray studies done on skeletal muscle of mice,
monkeys and humans, we also found that genes associ-
ated with metabolic functions, particularly energy path-
ways, were higher in young control animals (Table 1). In
contrast, genes indicative of cellular damage, such as stress
response and apoptotic genes, had higher expression lev-
els in the muscle tissue of older animals (Table 1).
Among the biological classes of transcripts with an age
effect, there were several gene families whose mRNA levels
were significantly increased or decreased with age [see
additional file 1]. There were 8 procollagen genes (11
probe sets) that were altered with aging; 7 of these showed
higher levels in the young muscle (col1a1, col1a2, col3a1,
col5a1, col6a1, col6a2, col6a3) while only one procollagen
gene was increased with aging (col17a1). The keratins,
important cytoskeletal structural proteins, were repre-
sented by 8 genes (9 probe sets) all of which displayed
increased transcript levels in older muscle. Three members
(alpha, beta and delta) of the CCAAT/enhancer-binding
protein (CEBP) family of transcription factors had
increased levels of transcripts in the older mice. The
encoded CEBP alpha, beta and delta proteins are impor-
tant in the regulation of genes involved in immune and
inflammatory responses, cell cycle arrest and body weight
homeostasis (for a review, see [18]). Because many genes
are represented more than once on the MOE430A Affyme-
trix microarray, several genes had multiple hits on our list
of genes with an age effect in skeletal muscle. Among
those genes with four or more independent listings were:
fibromodulin (6 probe sets, all with reduced expression in
the old), transferrin receptor (5 probe sets, all with reduced
expression in the old), immunoglobulin kappa chain variable
8 (4 probe sets, all with increased expression in the old),
and  myristoylated alanine rich protein kinase C substrate
(marcks) (4 probe sets, all with reduced expression in the
old).BMC Genomics 2007, 8:80 http://www.biomedcentral.com/1471-2164/8/80
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Transcript and Protein Levels of p53-Related Genes 
Altered with Aging
Given that skeletal muscle is largely a post-mitotic tissue,
we were surprised to find that a large number of genes
involved in the regulation of the cell cycle had increased
mRNA levels with age (5.2% of all genes with a statisti-
cally significant effect). Two gene products that are known
to play a critical role in initiating cell cycle arrest following
DNA damage, cyclin-dependent kinase inhibitor 1A (p21)
and growth arrest and DNA-damage-inducible, alpha
(GADD45a), were both increased significantly in the skel-
etal muscle of the aged mice. Expression levels for p21 and
GADD45a were 1.9 and 1.8 fold higher respectively in
older mouse compared to the younger animals. An age-
related increase in p21 has previously been observed in
muscle of both male and female humans (2.9 and 4.0 fold
respectively) [16,17] and monkeys (4.1 fold) [15], while
the expression of GADD45a has been shown to be ele-
vated in mouse gastrocnemius muscle (2.6 fold) [13] and
both male and female human muscle (2.0 and 1.9 fold
respectively) [16]. Because the expression of these two
genes is typically mediated by the action of p53, we
decided to systematically examine our list of genes differ-
entially expressed between young and old to determine if
there were any other transcripts that are also connected to
p53 activity. As shown in Table 2, the transcripts that are
activated by p53, or whose gene products are known to
bind to p53, increase significantly with age, while the
expression of genes that are known to inhibit p53 activity
decline in old muscle. The average CR prevention on these
p53-related genes was 77%.
To confirm the age-related changes in expression observed
in  p21  and  GADD45a  using microarrays, we probed
young, old and old CR mice using RT-PCR (Figure 1A).
We also examined the expression levels of the p53 gene
itself, along with the expression levels of another impor-
tant tumor suppressor, p16. Both p53 and p16 transcripts
were considered absent (below levels of background
hybridization) in all animals according to the Affymetrix
software, but we were able to detect expression using the
more sensitive method of RT-PCR. As is shown in Figure
1A, transcript levels for these genes increased significantly
(Student's t-test, P < 0.05) with age. Furthermore, old ani-
mals undergoing CR demonstrated reduced levels for
these genes compared to age-matched mice fed normal
diets (only the difference in p53 levels was considered sig-
nificant at P < 0.05). To examine how the expression of
p21, p16, GADD45a and p53 is altered over the course of
the adult mouse life span, we used RT-PCR to measure
transcript levels for these genes in gastrocnemius muscle
at 5 month intervals from 5 to 30 months of age (Figure
1B–E). With the exception of GADD45a (Figure 1D), the
increase in expression of these genes does not show a lin-
ear pattern with age. p16  and  GADD45a  expression
increases significantly only in the last third of the lifespan,
whereas expression of p53 and its transcriptional target
p21 occur as early as 10 months of age.
To determine whether the p53-mediated transcriptional
program observed in older mouse skeletal muscle trans-
lated into higher levels of p53-associated proteins being
expressed, we probed young, old and old CR muscle for
Table 1: Biological classes of probe sets with an age effect on transcription levels in young and old mouse muscle.
# transcripts with age effect P-value
Biological Process ↓Old ↑Old ↓Old ↑Old Ave. % CR Prevention
lipid metabolism (4.5%) 19 13 <0.0005 NS 101 ± 9
protein metabolism (16.3%) 55 61 NS NS 88 ± 5
carbohydrate metabolism (2.7%) 12 7 <0.05 NS 91 ± 15
energy pathways (1.7%) 10 2 <<0.0005 NS 100 ± 20
stress response (5.2%) 13 24 NS <0.05 90 ± 8
immune response (3.4%) 4 20 NS <0.005 99 ± 10
apoptosis (3.7%) 5 21 NS <<0.0005 62 ± 15
cell cycle (5.2%) 9 28 NS <0.005 66 ± 8
cell adhesion (4.1%) 18 11 <0.05 NS 49 ± 14
cytoskeleton organization and biogenesis (3.9%) 10 18 NS <0.005 102 ± 12
Given in the above table are some of the more predominate biological processes, as determined by Gene Ontology [59], represented in the probe 
sets considered differentially expressed (PP > .90) in young and old mouse skeletal muscle. The number in parentheses is the percent each biological 
class represents out of all probe sets shown to have an age effect (712 total probe sets). Because genes can have multiple functions, many probe sets 
are associated with more than one biological process. Listed in the two middle columns on the left are the number of transcripts whose expression 
either decreased (↓ Old) or increased (↑ Old) in older mouse muscle. The middle columns on the right give the probability of obtaining the given 
transcript numbers for each biological class by chance. The last column gives the average CR prevention ± SE for all of the probe sets associated 
with these biological classes. The % CR prevention was calculated for each gene in the following manner: 100 × (old expression levels - CR 
expression levels)/(old expression levels - young expression levels). NS = not significant.BMC Genomics 2007, 8:80 http://www.biomedcentral.com/1471-2164/8/80
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p53-transcriptional targets p21 and GADD45a. Western
immunoblot confirmed a significant increase in p21 pro-
tein (4.6 fold, P < 0.005) and GADD45a (1.6 fold, P <
0.05) in older mouse skeletal muscle (Figure 2). Levels for
these proteins were reduced in the old CR mice as com-
pared to old mice on the control diet (approximately 57%
and 77% of old levels for p21 and GADD45a respec-
tively). An attempt was made with several antibodies to
measure p53 protein levels (both phosphorylated and
non-phosphorylated isoforms) in GN muscle, but the sig-
nal from the Western blots was either absent or too low to
accurately quantitate p53 in any age group (data not
shown).
Transcript Levels of p21, p16 and GADD45a in Mouse 
Models of Increased Oxidative Stress
To test whether the changes in expression of the p53-
related genes could be attributed to cumulative oxidative
damage with age, we compared transcript levels for p21,
p16, GADD45a and p53 in C57BL/6 mice with a hetero-
zygous knockout for either glutathione peroxidase 4
(GPX4+/-) (5 mo old) or MnSOD (SOD2+/-) (~9 mo old)
mutations to age-matched wild-type mice. GPX4+/-mice
have approximately half the amount of mRNA and pro-
tein levels for this essential Se-dependent antioxidant pro-
t e i n  a s  c o m p a r e d  t o  w i l d  t y p e  m i c e  [ 1 9 ] .  M o u s e
embryonic fibroblasts (MEFs) derived from mice hetero-
zygous for the gpx4 gene show increased evidence of lipid
and DNA oxidation, and are sensitive to gamma irradia-
tion [19,20]. SOD2+/- mice show a ~50% reduction in
MnSOD protein content and MnSOD activity in gatrocne-
mius tissue [21] and have increased oxidative damage as
demonstrated by significantly elevated levels of 8-oxo-2-
deoxyguanosine (8oxodG) in both nuclear and mito-
chondrial DNA in all surveyed tissues compared to wild
type mice [22]. RT-PCR analysis of p21, p16, GADD45a
and p53, in GPX4+/- mice showed a significant increase (P
< 0.005) in p53 expression compared to the age-matched
wild-type mice. We did observe a ~2 fold increase in p16,
although it was not statistically significant (P < 0.12).
Transcript levels of these genes were not significantly dif-
ferent between SOD2+/- mice and age-matched controls
[see additional file 2]. Thus, constitutive oxidative damage
does not always trigger the expression of the genes exam-
ined. Possibly, different types of DNA damage in GPX4-/
+ and SOD2+/- mice explain the observed differences.
Table 2: Age-related effects on expression of p53-related genes in young and old C57BL/6 mouse gatrocnemius tissue.
Gene Expression Ratio % CR Prevention Posterior Probability Representative Public ID
Genes That Encode Proteins That Bind P53
myogenic differentiation 1 1.52 101 0.9983 NM_010866
pleiomorphic adenoma gene-like 1 1.59 153 0.9987 AF147785
Genes Whose Expression is Activated by P53 Activity
p21 1.92 67 1.0000 AK007630
GADD45a 1.79 44 1.0000 NM_007836
DNA-damage-inducible transcript 4 1.39 -2 0.9980 AK017926
dual specificity phosphatase 1 1.51 43 0.9992 NM_013642
IGF binding protein 3 1.28 106 0.9875 AV175389
keratin complex 1, acidic, gene 15 1.26 94 0.9890 NM_008469
mcl1 1.44 52 0.9894 BC003839
mcl1 1.45 27 0.9790 AV274748
mcl1 1.46 11 0.9539 AV318494
p53 apoptosis effector related to Pmp22 1.75 133 1.0000 NM_022032
sestrin 1 1.43 103 1.0000 BG076140
sestrin 1 1.44 60 0.9999 AV016566
pten 1.46 114 0.9798 AA214868
paternally expressed 3 1.52 99 0.9962 BM200248
retinoblastoma 1 1.50 63 1.0000 NM_009029
Genes That Inhibit P53 Activity
B-cell leukemia/lymphoma 6 0.60 130 1.0000 U41465
cyclin G1 0.63 110 0.9980 BG065754
dual specificity phosphatase 10 0.48 46 1.0000 NM_022019
dual specificity phosphatase 10 0.66 49 0.9990 NM_022019
mdm2 0.63 90 0.9999 X58876
The above p53-related genes were selected from a list of 712 transcripts that were determined to be differentially expressed in young and old 
gastrocnemius mouse tissue using an empirical Bayes (EB) hierarchical modeling approach called EBarrays [56, 57] at posterior probability (PP) > 
.90. Genes listed more than once represent independent probes on the MOE430A array for the same gene identified in this statistical screen. 
Expression ratio = old (O) expression levels/young (Y) expression levels.BMC Genomics 2007, 8:80 http://www.biomedcentral.com/1471-2164/8/80
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p21, p16, Gadd45a and p53 expression in mouse skeletal muscle Figure 1
p21, p16, Gadd45a and p53 expression in mouse skeletal muscle. (A) Relative expression ratio ± SE for mRNA levels, 
as determined by RT-PCR, for p21, p16, Gadd45a and p53 in young (5 month old), old (25 month old), and old CR (n = 5 for 
each group). (B-E) Relative expression ratio ± SE for mRNA levels for these genes over the course of the adult mouse life span 
(5 to 30 months of age). The mean of 5 mice ± SE was used for each data point on the graphs. Two-tailed Student's t-test; *P < 
0.05 (young versus old) and †P < 0.05 (old verses old CR).
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Protein levels for p21 and GADD45a in mouse skeletal muscle Figure 2
Protein levels for p21 and GADD45a in mouse skeletal muscle. (A) Representative western blot for p21 and 
GADD45a staining in young, old and old CR skeletal muscle. (B) Expression ratio information on protein levels (n = 3 and n = 
4 for p21 and Gadd45a respectively for each age and diet). One-tailed Student's t-test; *P < 0.05, **P < 0.005 (young verses 
old), †P < 0.005 (old versus old CR).
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Increased p53 Levels in Older Muscle is Associated with 
Increased Expression of Genes Involved in p53-Mediated 
Apoptosis
A critical function of p53 is the induction of apoptosis in
cells that have undergone DNA damage or exhibit uncon-
trolled cellular growth [23]. To investigate whether
increased p53 activity with age is associated with tran-
scription profiles indicative of apoptosis in old gastrocne-
mius muscle, we examined mRNA levels of four genes
known to be key transducers of p53-mediated apoptosis:
Bcl-2 binding component 3 (bbc3/puma) [24], phorbol-12-
myristate-13-acetate-induced protein 1 (pmaip1/noxa) [25],
tumor necrosis factor receptor superfamily, member 10b
(tnfrsf10b/killer/dr5) [26] and Bcl-2-related ovarian killer
protein (bok) [27]. We observed a significant increase in
mRNA levels with age for these genes in mouse gastrocne-
mius muscle and a significant decrease in levels due to
caloric restriction in old, age-matched controls (Figure
3A). The expression levels for all of these p53-mediators
of apoptosis were also examined in the gastrocnemius
muscle over the course of the mouse adult lifespan (Figure
3B–E), and increased levels of transcript were usually
observed in the first half of the lifespan. We also com-
pared the levels for these proapoptotic genes in the gas-
trocnemius tissue of GPX4+/- and the SOD+/- mice to age-
matched wild type mice using RT-PCR. Only the levels for
tnfrsf10b were considered significantly higher (P < 0.005)
in the GPX4+/- mice while expression of these genes was
not significantly different in the SOD2+/- mice [see addi-
tional file 3]. These findings indicate that p53-dependent
mediators of apoptosis are regulated with age and that the
mechanism of activation is independent of endogenous
levels of oxidative stress.
Increase in mRNA Levels of p53 and p53-Associated Genes 
in Multiple Tissues of Old C57Bl6/J Mice
To determine whether the p53-mediated transcriptional
program we observe in older skeletal muscle may also
occur in other tissues, we used RT-PCR to measure mRNA
levels of p53-associated genes in heart, lung, liver, kidney,
brain and intestine of young, old, and old CR mice (Table
3). Transcript levels for p21, p16, p53 and pmaip1 demon-
strated increased levels in multiple tissue types in the old
mice, while an increase in transcript levels for gadd45a,
bbc3, tnfrsf10b and bok was only observed in old skeletal
muscle. These findings suggest that activation of a p53-
mediated transcriptional program may be a common fea-
ture of aging in multiple tissues, but the pattern of expres-
sion of p53-dependent genes is tissue specific.
Discussion and conclusion
Our initial investigation of muscle aging in mice revealed
many differences in the transcriptional patterns between
young and old mice [13]. In general, transcript levels for
genes that are associated with cellular damage were ele-
vated in older muscle, while transcript levels for genes
involved in energy metabolism were reduced with age.
The current study further demonstrates that the intrinsic
transcriptional patterns are altered with aging in mouse
skeletal muscle. As with other microarray studies done on
older mammalian muscle [13-17], we have also found a
disproportionate number of metabolic genes, such as
those involved in lipid and carbohydrate metabolism,
decrease in transcription levels with age. The age-related
decrease in expression of these energy-associated classes
likely reflects the reduction in mitochondria observed in
older gastrocnemius muscle. For example, a 23–25%
reduction in mtDNA copy number and a corresponding
17–22% reduction in the expression of mitochondrial
DNA-encoded cytochrome c oxidase (COX) subunits I
and III was previously reported in old rat gastrocnemius
tissue [28]. In our study, out of 25 transcripts that are asso-
ciated with the mitochondria, the expression of 18 of
these probe sets are significantly reduced with age (PP <
.90) [see additional file 1]. Conversely, genes associated
with the stress and immune response, such as those
involved in the induction of apoptosis or the response to
DNA damage, have elevated mRNA levels in the older ani-
mals. The age-associated increase in genes that are acti-
vated during cellular stress and injury is probably in
response to a wide variety of biological damage known to
accumulate in older muscle over the course of the lifespan
[9,10,12]. We also observed that the expressions of a large
number of genes involved in the regulation of the cell
cycle were increased with age in mouse skeletal muscle. A
closer examination of these cell cycle genes revealed a pat-
tern of expression indicative of increased p53 activity in
older mouse muscle (Table 2).
Welle et al. also found transcriptional evidence of
increased p53 activity with age in the skeletal muscle of
young (20–29 yrs. old) and old (65–71 yrs. old) women
[16]. In their study, genes that regulate or enhance p53
activity (Pin1, p57 and Wrn) or that are induced by p53
(p21 and GADD45a) demonstrate increased expression in
older female muscle. Based on this evidence, Welle and
coworkers suggested that future studies should examine
the possibility that p53 levels or activity are increased in
older muscle. One possible mechanism for the observed
increase in p53 activity is elevated levels of DNA damage
with age. The concentration of 8-oxo-2 deoxyguanosine
(oxo8dG), a byproduct of DNA oxidation, has been
observed to increase with age in a variety of tissues,
including skeletal muscle, in rats and various strains of
mice (CR reduced the levels of oxo8dG in most of these
tissues) [29]. We tested this hypothesis by examining the
levels of p53 mRNA and related transcripts in transgenic
mice with half the wild type levels of antioxidants GPX4
or SOD2. These mice have elevated levels of oxidative
DNA damage yet failed to show any significant increase inBMC Genomics 2007, 8:80 http://www.biomedcentral.com/1471-2164/8/80
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RT-PCR of proapoptotic bbc3, pmaip1, tnfrsf10b and bok expression in mouse skeletal muscle Figure 3
RT-PCR of proapoptotic bbc3, pmaip1, tnfrsf10b and bok expression in mouse skeletal muscle. (A) Relative 
expression ratio ± SE for mRNA levels of p53-mediated apoptotic genes in young, old, and old CR (n = 5 for each group). The 
mRNA levels for these four genes were also measured using RT-PCR in 5–30 month old C57BL/6NHsd mouse gastrocnemius 
muscle (B-E) (mean ± SE of 5 animals per age group). Two-tailed Student's t-test; *P < 0.05, **P < 0.005 (young verses old), †P 
< 0.05 (old versus old CR).
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expression of p21 and GADD45a, two well studied p53-
induced genes [see additional file 2]. The GPX4+/- mice did
display a significant increase in transcript levels for p53 as
compared to age-matched controls, but no change was
observed for the SOD2+/- mice. Possibly, different types of
DNA damage impact the expression of these genes differ-
ently. Another possibility is that the DNA damage signal-
ing that is the trigger for activation of p53 in old muscle
originates from chromosomal damage, such as double-
strand breaks or telomere shortening, rather than from
oxidative alterations. We also note that there are two likely
possibilities for the cellular origin of the alteration in
expression of cell cycle regulators. One is that these alter-
ations in gene expression reflect a decline in proliferation
of a muscle-associated cell such as the satellite cell. It has
recently been reported that hematopoietic stem cell num-
bers are higher in old mice with reduced p53 activity
(p53+/-) and fail to increase with age in old mice with
hypermorphic p53 activity (p53+/m) as compared to their
wild type counterparts [30]. A second possibility is that
the expression of these genes reflects a general p53-medi-
ated DNA damage response associated with age-related
DNA modifications in myocytes.
Many recent studies have linked tumor suppressor activ-
ity, in particular the tumor suppressor p53, to organismal
aging [23,31-34]. p16INK4a, a product of the INK4a/ARF
(Cdkn2a) locus also increases in expression with age in
most tissues as shown in previous studies [35-37] and also
in the current analysis. This increase in p16INK4a expres-
sion with age has recently been shown to contribute to
age-dependent decline in regenerative potential of pancre-
atic islet regenerative capacity [38], decreases in forebrain
progenitors and neurogenesis [39] and the decrease in
hematopoietic stem cell repopulation defects [40]. How-
ever, we note that it is possible that only rare cells in tis-
sues express p16INK4a with aging. Under these conditions,
a large effect of increased ROS in a specific biologically rel-
evant muscle compartment (e.g. satellite cells) could be
missed by studying unfractionated muscle as we did in
our analysis. Thus, the induction of a cell senescence and
apoptotic program with age may underlie key features of
the aging process.
Given our finding that mRNA levels for p53-associated
genes were elevated in multiple tissues of old mice (Table
3), our data suggests that increased p53 activity is not lim-
ited to aging muscle but is also an overall consequence of
organismal aging. Increased p53 mRNA levels is observed
in the grey and white matter of the cortex, cerebellum, and
medulla oblongata of old (24 month old) verses young
(3.0–3.5 months old) rat brains and an increase in p53
protein levels is observed in the grey matter of old rats
[41]. We did not find a significant difference in p53 gene
expression between young and old brains, but our analy-
sis was performed on whole brain homogenates and
therefore any age-effect on p53 expression within the dif-
ferent regions of the brain might have been missed. Fur-
ther support for the role of increased p53 activity
contributing to aging process comes from transgenic stud-
ies in mice that express overactive p53 and also demon-
strate accelerated aging [42,43]. Mice with augmented p53
function develop typical age-associated phenotypes such
as delayed wound healing, reduced hair growth and
reduced subcutaneous adipose tissue much earlier than
their p53 wild type counterparts. Conversely, the long-
lived p66Shc-/- mouse, shown to have a 30% extended life
span, exhibits impaired p53 apoptotic signaling [44]. Our
study demonstrates that the majority of the p53-related
transcriptional changes observed in old skeletal muscle
are either completely or partially reversed through caloric
restriction, a proven method to extended longevity. Based
on the evidence for the involvement of the p53 pathway
in organismal aging, it follows that p53 and p53 transcrip-
tional targets have the potential to be good biomarkers of
aging in multiple tissue types.
Table 3: Age-associated effects on the transcript levels of p53-related genes in various tissues of C57Bl6/J mice.
Expression Ratio (%CR Prevention)
p21 p16 p53 Pmaip1
muscle 2.2*(38%) 2.0*(65%) 1.4*(115%) 2.7**(79%)
heart 3.3*(104%) 2.6**(42%) NSC 1.6*(104%)
lung  NSC 4.2*(62%) NSC 1.7 (65%)
liver 2.6 (103%) 5.7**(23%) 1.5 (349%) 1.6 (116%)
kidney 1.6*(-37%) 11.2*(55%) 1.3*(94%) 1.4 (136%)
brain NSC 6.6**(28%) NSC 1.7**(34%)
intestine 1.5 40.6** NSC 6.8*
Listed above are genes that are components of the p53 signaling pathway that show an age effect on expression in multiple mouse tissue-types. 
Expression ratio (O/Y) information is given for each gene if there was a significant difference (P < 0.05) in transcript levels, as determined by RT-
PCR, between young and old or if this difference exceeded 1.2 fold and there was at least a 50% caloric restriction (CR) prevention. A total of 5 
mice were used for each age group and diet (mRNA from CR mice were pooled together) for heart and muscle while 4 mice per age and diet were 
used for the remaining tissue types. No intestinal samples were available for old CR mice and therefore no values are given for this tissue for CR 
prevention. Statistical significance was determined using two-tailed Student's t-test, *P < 0.05; **P < 0.005. NSC = no significant change.BMC Genomics 2007, 8:80 http://www.biomedcentral.com/1471-2164/8/80
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It has been well documented that there is a significant
decrease in muscle mass with age, yet little is known as to
the actual mechanism for this loss of tissue. It has been
hypothesized that the decrease in muscle fiber can be
attributed to increased apoptosis with age. In fact, an
increase in biological markers of apoptosis, such as DNA
fragmentation and proapoptotic caspase-type proteins,
are increased with age in human [45] and rat skeletal mus-
cle [46,47]. However, the mechanism for this age-associ-
ated apoptosis is unknown. It has been suggested that
increased oxidative damage to the mitochondria, along
with sarcoplasmic reticulum stress in older skeletal mus-
cle could initiate caspase activation and lead to the apop-
totic pathway that ultimately results in the destruction of
the aged myocyte [47]. Moreover, Dirks and Leeuwen-
burgh also observed a significant reduction in DNA frag-
mentation (mono- and oligonucleosomes) and caspase
levels in old (26 month old) rats on lifelong caloric
restriction when compared to their age-matched, ad libi-
tum-fed counterparts. The authors suggest the reduction
of apoptosis in response to caloric restriction is due to
reduced mitochondrial oxidant production and nuclear
oxidative DNA damage in skeletal muscle [48]. Our
results do not support this hypothesis. Although young
GPX4+/-  mice did show increased levels of expression,
compared to wild-type young mice, of p53-associated
mediator of apoptosis tnfrsf10b, little or no change was
observed for bbc3 and bok (only tnfrsf10b was considered
significant at P < 0.05). The SOD2+/- mice, on the other
hand, demonstrated almost identical levels of expression
for all of the surveyed p53 mediators of apoptosis to the
age-matched, wild type controls. It is possible that
increased oxidative damage may play a role in p53-medi-
ated apoptosis in older muscle, but our data suggests that
it may not be the sole causative effect. Old calorie
restricted mice displayed a significant decrease in expres-
sion levels of all four of the p53-mediators of apoptosis
compared to the normally fed old mice. It is clear that
caloric restriction has an inhibitory effect on age-associ-
ated apoptosis of skeletal muscle, but this prevention may
not be completely explained by the reduction of endog-
enous reactive oxygen species and the resulting decrease
in oxidative DNA damage in these animals.
The role of p53 in the aging process of skeletal muscle is
likely to be a complex process involving many different
cellular effectors. Various proteins and pathways interact
with p53 to modulate its activity. Furthermore, there are
numerous p53-transcriptional targets, each with their
own associated modulators that may influence muscle
aging. As evidence of this complexity, we show that the
expression profiles for p53-regulated genes are not identi-
cal to that of p53, as well as to each other, over the course
of the mouse adult lifespan in gastrocnemius muscle (Fig-
ure 1B–E, Figure 3B–E). Future studies will concentrate on
determining which specific components of the p53 path-
way play a functional role in muscle aging, and organis-
mal aging in general.
Methods
Animal treatments
Male C57BL/6NHsd mice were purchased from Harlan
Sprague-Dawley at 6–7 weeks of age and individually
housed for the remainder of their lifespan. Upon arrival to
our facility, mice were fed one of two life-long dietary reg-
imens: normal diet (ND) and caloric restriction (CR).
Mice on ND were provided acidic water ad libitum and
fed 84 kcal/wk which is ~15% less than the average ad
libitum diet. C57BL/6NHsd mice on this dietary regiment
typically have an average lifespan of 30 mo. in our colony.
Mice on CR were fed a diet that resulted in a 26% differ-
ence in caloric intake to the ND animals. The diet fed to
CR mice was enriched in protein, vitamins and minerals
such that CR and ND mice were fed nearly identical
amounts of these components. Detailed information on
diet composition and feeding for ND and CR mouse diets
have previously been described [49]. Five replicate mice
were used for each diet and age group for microarray anal-
ysis. Dissected gastrocnemius muscle from the mice were
flash-frozen in liquid nitrogen and stored at -80°C until
processed for microarray or Western analysis.
Tissue preparation and oligonucleotide array 
hybridization
RNA was extracted from frozen mouse tissue, transcribed
to cDNA which was then used as a template to produce
biotin-labeled cRNA as previously described [50]. A total
of 10 µg of fragmented cRNA was used for hybridization
to each MOE430A array (Affymetrix, Santa Clara, CA).
After hybridization, the arrays were washed and stained
with signal amplification protocol using antibody. The
arrays were scanned twice and the averaged images were
used for further analysis.
Data analysis
The complete set of gene expression data has been depos-
ited in the Gene Expression Omnibus database [51] acces-
sion # [GSE6323]. Robust Multi-Array Analysis (RMA)
was used to pre-process and normalize the raw Affymetrix
GeneChip data [52]. RMA is available in Bioconductor
[53], an open source and open development software
project for the analysis and comprehension of genomic
data based primarily on the R programming language
[54]. RMA fits a log-scale linear model to derive a single,
normalized, summary score of expression for each probe
on each array. RMA has been shown to provide greater
sensitivity and specificity in detection of differentially
expressed genes than the Affymetrix analysis software
MAS 5.0 [52,54]. Because RMA generally provides attenu-
ated estimates of fold-change [55], the values reported inBMC Genomics 2007, 8:80 http://www.biomedcentral.com/1471-2164/8/80
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the expression ratios for the array data are likely minimal
estimates. MAS5.0 was used to compute absent/present
calls. Any gene considered absent across all 15 arrays was
removed from the analysis. This left 10,892 probes (out of
22,690).
Statistical analysis
To identify genes differentially expressed over time, we
used an empirical Bayes hierarchical modeling approach
called EBarrays [56,57], also implemented in Bioconduc-
tor [54]. To briefly illustrate EBarrays, first consider the
simple case of two biological conditions. For a given gene
g, there are then two underlying levels of expression, one
in each condition. These are the quantities of interest that
are approximated by the expression measurements. Of
most interest is the relationship between these means. In
the case of equivalent expression (EE), the two means
denoted by µg1 and µg2 are equal; µg1 ≠ µg2 denotes dif-
ferential expression (DE). We refer to these equality and
inequality relationships as expression patterns.
EBarrays assigns a probability to each gene for each pat-
tern. To do this, the probability distribution governing the
data must be described. A Gamma-Gamma (GG) model is
often used. For that model, we assume the underlying
expression levels are approximately distributed as Inverse
Gamma; and, for a given gene g in condition k (in our
simple example, k = 1,2), measured intensities arise from
a Gamma distribution with mean µgk. The Inverse
Gamma distribution here describes variation in the true
underlying intensity levels of different genes (some genes
have low expression, others high) and the Gamma distri-
bution describes within gene variability due to biological
and technical error variations. Similarly, a log-Normal
Normal (LNN) model can also be used, where the under-
lying expression levels are assumed Gaussian, and log
intensities for gene g in condition k are considered as Nor-
mally distributed with mean prescribed by µgk. Since we
never know which genes are in which patterns, the full
data distribution is given by a mixture: there is some prob-
ability p that the data for a given gene arise from pattern
DE and a (1-p) chance that the data are EE.
For both cases, model parameters are determined by fit-
ting the model to the full set of array data (details are
given in [57]). In this way, the approach utilizes informa-
tion across genes and arrays to optimize model fit, and is
thus more efficient than a number of methods that make
gene inferences one gene at a time. Once model parame-
ters are obtained, probabilities for each pattern are calcu-
lated for every gene. These probabilities are referred to as
posterior probabilities, since they are calculated after
observing a set of data. For a given gene and expression
pattern, the posterior probability quantifies evidence that
the gene is in that pattern. Posterior probability thresh-
olds can be set to control the false discovery rate (FDR) at
a desired level [58]. For example, defining DE genes to be
those with a posterior probability of DE exceeding 0.95
controls the FDR at 0.05.
This approach, described for two conditions, extends nat-
urally to multiple conditions. Whereas for two biological
conditions there are only the EE and DE patterns to con-
sider, for multiple conditions there are many patterns.
Given the three conditions here (young, old, and old CR),
5 expression patterns are possible (µ1 = µ2 = µ3; µ1 ≠ µ2
= µ3; µ1 = µ2 ≠ µ3; µ1 = µ3≠µ2; µ1≠µ2≠µ3). Model fit pro-
ceeds as in the two-pattern case (the details of the multiple
pattern case are also given in [57]). Posterior probabilities
for each of the 5 patterns were calculated for 10,892 genes
under both GG and LNN assumptions. The appropriate-
ness of model assumptions was checked using diagnostic
plots. In most cases, results were similar for both models
and only results from the LNN model are reported.
Real-time (RT)-PCR
Total RNA was extracted from frozen tissue using the TRI-
ZOL reagent (Life Technologies, Grand Island, NY). Poly-
adenylate [poly(A)+] RNA (mRNA) was then purified
from the total RNA with oligo-dT-linked oligotex resin
(Qiagen, Valencia, CA). Isolated mRNA was reverse tran-
scribed to cDNA and amplified using the TaqMan EZ RT-
PCR Kit (Applied Biosystems, Foster City, CA) (5 ng
mRNA per 25 µl RT-PCR reaction volume). All primers
and fluorescent probes for assayed genes, with the excep-
tion of the custom-made p21 and p16, were purchased
from Assays-on-Demand Gene Expression probes
(Applied Biosystems, Foster City, CA). The gene symbol
and Applied Biosystem assay number for all Assays-on-
Demand primer/probe sets used for RT-PCR are as fol-
lows:  gadd45  (Mm00432802_m1),  p53
(Mm00441964_g1),  bbc3  (Mm00519268_m1),  pmaip1
(Mm00451763_m1), tnfrsf10b (Mm00457866_m1), bok
(Mm00479422_m1), tbp (Mm00446973_m1), and gapd
(Mm99999915_g1). The sequence for the primers and
probes for p21 and p16 are as follows: for p21, forward 5'-
GGCAGACCAGCCTGACAGAT-3', reverse 5'-TTCAG-
GGTTTTCTCTTGCAGAAG-3', and probe 5'-TCTAT-
CACTCCAAGGCA-3'; for p16, forward 5'-
CCCAACGCCCCGAACT-3', reverse 5'- GCAGAAGAGCT-
GCTACGTGAA-3', and probe 5'-TTCGGTCGTAC-
CCCGATTCAGGTG-3'. The sequence for the RT-PCR
probe and primer for p16 was provided to us by Norman
Sharpless's research group. The expression of TATA box
binding protein (tbp) and glyceraldehyde-3-phosphate dehy-
drogenase (gapd), which showed approximately the same
expression levels as measured on the microarrays for all
animals regardless of age or diet, was used to normalize all
RT-PCR results. RT-PCR was performed and quantifiedBMC Genomics 2007, 8:80 http://www.biomedcentral.com/1471-2164/8/80
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using the ABI PRISM 7000 Sequence Detection System
(Applied Biosystems, Foster City, CA).
Western immunoblot
Tissues homogenate was prepared from frozen in modi-
fied RIPA buffer (Tris-HCL 50 mM pH 7.4, NP-40 1%, Na-
deoxycholate 0.25%, NaCl 150 mM EDTA 1 mM) con-
taining protease and phosphatase inhibitors (Sigma).
One hundred micrograms of each tissue extract were sep-
arated on 12.5% SDS PAGE gel (BioRad) and transferred
to PVDF membrane (Pierce). Membranes were blocked in
5% milk in Tris buffered saline 0.1% Tween 20 (TBST) for
1 hour. Membranes were incubated in primary antibody
overnight at 4°C with agitation in either 5% milk or 5%
BSA in TBST at the indicated dilutions (GADD45A Santa
Cruz Biotechnology Inc. 1:500; p21/WAF1 Ab-6 Calbio-
chem 1:4000; Tubulin Sigma 1:2000). After 3 × 5 min
washes, the membranes were incubated in HRP conju-
gated secondary antibody (Vector labs, 1:10,000 dilution)
for 1 hour at room temperature. Membranes were washed
as before, incubated in SuperSignal West Pico Chemilu-
minescent Substrate (Pierce) and exposed to film (Pierce).
Band density was calculated using NIH Image J software.
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